This Metric Says You Are Smart to Buy ISIS Pharmaceuticals, Inc. (ISIS)

Page 2 of 2

With the returns exhibited by our strategies, retail investors must always keep an eye on hedge fund and insider trading sentiment, and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) is no exception.

Click here to learn why you should track hedge funds

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
United Therapeutics Corporation (NASDAQ:UTHR) 13 1 7
Cubist Pharmaceuticals Inc (NASDAQ:CBST) 22 0 8
Amarin Corporation plc (ADR) (NASDAQ:AMRN) 19 0 0
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 8 0 0
The Medicines Company (NASDAQ:MDCO) 20 0 8
Page 2 of 2